Search Results - "Vinolas Segarra, N"
-
1
-
2
-
3
LungBEAM: A prospective multicenter trial to monitor EGFR mutations using BEAMing technology in stage IV NSCLC patients
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
4
-
5
125P Assessing the accuracy of multiple prognostic scores for immune checkpoint inhibitors (ICI) in patients with advanced solid tumors
Published in Annals of oncology (01-09-2022)Get full text
Journal Article -
6
24P Preliminary data on INHERITY LC: Germline mutations of a cohort of selected non-small cell lung cancer (NSCLC) patients
Published in Annals of oncology (01-09-2022)Get full text
Journal Article -
7
939P Changes in immune gene signatures after neoadjuvant chemoimmunotherapy treatment in NSCLC patients from NADIM trial
Published in Annals of oncology (01-09-2022)Get full text
Journal Article -
8
157MO Immune gene signatures for predicting pathological response of NSCLC patients treated with neoadjuvant chemoimmunotherapy
Published in Annals of oncology (01-04-2022)Get full text
Journal Article -
9
138P Prevalence and characteristics of lung cancer in families harboring pathogenic germline variants in cancer predisposing genes
Published in Annals of oncology (01-04-2022)Get full text
Journal Article -
10
-
11
548P Molecular pre-screening using comprehensive gene panels offered by clinical trials (CT)
Published in Annals of oncology (01-09-2020)Get full text
Journal Article -
12
109P Subpopulations of peripheral blood lymphocytes and response to immunotherapy across cancer-types
Published in Annals of oncology (01-09-2020)Get full text
Journal Article -
13
HOXA-related long non-coding RNAs impact prognosis in early stage NSCLC patients
Published in Annals of oncology (01-09-2017)Get full text
Journal Article -
14
-
15
-
16
121PLungBEAM: A prospective multicenter trial to monitor EGFR mutations using BEAMing technology in stage IV NSCLC patients
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
17
158P Neoadjuvant treatment in stage III NSCLC: Comparison with NADIM 2 trial as a gold standard
Published in ESMO open (01-03-2024)Get full text
Journal Article -
18
48P Real-world clinical utility of next-generation sequencing ctDNA for patients with advanced lung squamous cell carcinoma
Published in ESMO open (01-03-2024)Get full text
Journal Article -
19
-
20